Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000898430-07-003185
Filing Date
2007-08-17
Accepted
2007-08-17 13:28:14
Documents
1
Period of Report
2007-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd169953.html 4  
1 FORM 4 rrd169953.xml 4 22369
  Complete submission text file 0000898430-07-003185.txt   24555
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Issuer) CIK: 0001137883 (see all company filings)

EIN.: 912061050 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MORGAN & MORGAN BUILDING PASEA ESTATE, ROAD TOWN TORTOLA D8 VG 11 10
Business Address MORGAN & MORGAN BUILDING PASEA ESTATE, ROAD TOWN TORTOLA D8 VG 11 10 972 2 652-2363
ACCBT Corp. (Reporting) CIK: 0001406303 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 333-61610 | Film No.: 071064639